Larkspur Health Acquisition Corp.

NasdaqGM:LSPR Stock Report

Market Cap: US$75.2m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Larkspur Health Acquisition Management

Management criteria checks 0/4

Key information

Dan O'Connor

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure1.4yrs

Recent management updates

Recent updates

ZyVersa Therapeutics to go public through deal with SPAC Larkspur Health Acquisition

Jul 20

CEO

Dan O'Connor (57 yo)

1.8yrs

Tenure

Mr. Daniel J. O'Connor, J.D., also known as Dan, serves as President since 2022 and Chief Executive Officer at Ambrx Biopharma Inc. since November 2022 and serves as its Director since November 1, 2022. He...

Board Members

NamePositionTenureCompensationOwnership
Daniel O'Connor
Chairman of the Board & CEO1.8yrsno datano data
David Briones
CFO, Treasurer1.3yrsno datano data
Gregory Skalicky
Independent Director1.4yrsno data0.086%
$ 64.7k
Christopher Twitty
Independent Director1.4yrsno data0.086%
$ 64.7k
Raj Mehra
Director1.4yrsno data0.086%
$ 64.7k

1.4yrs

Average Tenure

50yo

Average Age

Experienced Board: LSPR's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.